Three artificial intelligence ethics questions manufacturers face right now

whitePaper | April 26, 2022

Perhaps the most visible aspect of Industry 4.0 is the concept of the ‘smart factory’, a term that typically conjures up images of automated factories leveraging AI, big data and robotics to make manufacturing more efficient, innovative and … well, smarter. That’s a simple take on what in reality will be a complex undertaking that will be an evolutionary journey that manufacturers will take over the next decade or so. Consequently, it’s helpful to approach the smart factory concept in terms of what parts of the existing manufacturing process you want to make smarter, and the foundational technologies that will help you achieve that.

whitePaper | October 11, 2022

The World Economic Forum, in collaboration with Accenture and EPRI, launched the “Transitioning Industrial Clusters towards Net Zero” global initiative at COP26 in Scotland, to accelerate the transition of industrial clusters globally towards net-zero emissions. This initiative promotes and enables industries to realize the benefits of co-location and take an integrated approach to transitioning towards net zero. Industrial clusters are where sector-specific decarbonization efforts and clean energy technology deployment efforts converge to enable a systemic approach towards industrial decarbonization

whitePaper | September 21, 2022

In its early days, 3D Printing reinvented the prototyping process by allowing a faster and more cost-efficient way to create new products. The effortless experimentation with CAD designs and the production of proof-of-concepts with almost no design limitations or material waste, revolutionized the prototyping world.

whitePaper | October 25, 2022

Traditionally, early-stage and late-stage process development have been done separately, with early-stage mostly focused on material production and late-stage on process intensification. As more molecules in development fall under an orphan or fast-track indication, the traditional approach of linear development stages can be counterproductive—not to mention expensive—due to investing resources in perfecting a process prior to early clinical phase success.

whitePaper | June 6, 2021

Three-dimensional (3D) printing is a powerful technology that has wide-ranging applications, including many in the pharmaceutical industry. Among the approaches that are being explored in the production of pharmaceutical dosage forms powder-based systems which utilize either drop-on-powder or selective laser sintering and liquid-based systems which use dropon-drop deposition or stereolithography are frequently applied. With liquid-based technology, either UV, laser energy or high temperature is used to induce polymerization and build the 3D structure.1 The process of 3D printing offers the potential to produce medications tailored to the needs of patients and dosage forms in various shapes, sizes and textures with different release profiles that can be difficult to produce using conventional techniques.2

whitePaper | April 11, 2022

Driven by the need to make parts faster, better, and for less, manufacturers of all sizes are embracing various forms of automation in the quest to lower costs, increase production, and reduce response times. Discover how incorporating fixed industrial scanning and machine vision solutions can help improve quality in every stage of the production process.